A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix(R)) with corresponding monovalent vaccines (Havrix(R) and Engerix-B(R)) in adults

By Joines R.W.   Blatter M.   Abraham B.   Xie F.   De Clercq N.   Baine Y.   Reisinger K.S.   Kuhnen A.   Parenti D.L.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4710-4719

Elsevier

Access to resources Recommend Favorite

HBVax II in non-responders to Engerix B

By Boxall E.   Dennis M.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 877-879

Elsevier

Access to resources Recommend Favorite

Immunogenicity of 10 and 20 g hepatitis B vaccine in a two-dose schedule

By ul-Haq N.   Hasnain S.S.   Umar M.   Abbas Z.   Valenzuela-Silva C.   Lopez-Saura P.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3179-3185

Elsevier

Access to resources Recommend Favorite

Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance

By Clemens R.   Sanger R.   Kruppenbacher J.   Hobel W.   Stanbury W.   Bock H.L.   Jilg W.  

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 349-352

Elsevier

Access to resources Recommend Favorite

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

By Davis H.L.   Suparto I.I.   Weeratna R.R.   Jumintarto   Iskandriati D.D.   Chamzah S.S.   Ma'ruf A.A.   Nente C.C.   Pawitri D.D.   Krieg A.M.   Heriyanto   Smits W.   Sajuthi D.D.  

Vaccine, Vol. 18, Iss. 18, 2000-03 ,pp. : 1920-1924

Elsevier

Access to resources Recommend Favorite